Evidence map›Paper›PMID 41063333›Full record

ArticlePediatric dermatology

Visualizing Genetics: An Investigation of Dermoscopy as a Tool for Genetic Variant Prediction in Capillary Malformations.

Aretha On, Marie-Chantal Caussade, Allison Britt, Sarah E Sheppard, Denise Adams, Griffin Stockton Hogrogian, James R Treat

Abstract read
In one paragraph

Article in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aretha OnPerelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0009-0002-3221-5391
Marie-Chantal CaussadeSection of Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Allison BrittComprehensive Vascular Anomalies Program, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-6601-0453
Sarah E SheppardComprehensive Vascular Anomalies Program, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-3480-8123
Denise AdamsComprehensive Vascular Anomalies Program, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Griffin Stockton HogrogianSection of Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
James R TreatPerelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

Cellular and Molecular Mechanisms of Vascular MalformationsZIAHD009003 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI SHEPPARD, SARAH · 2022 to 2025
$6.1M
Intramural NIH HHS ZIA HD009003Intramural Research Program of the National Institutes of Health (NIH)
6 · The paper itself

Abstract

BACKGROUND/

objectivesCapillary malformations (CMs) are congenital malformations of capillaries typically visible as blanchable, pink to brown patches on the skin and/or mucosa. The genetic cause of CMs guides diagnosis, treatment, and recurrence counseling. However, identification may be limited by the availability of samples, the type of tests, and insurance coverage. We hypothesize that there are distinct dermoscopic features associated with specific genotypes of congenital CMs.

methodsA single-center, retrospective cohort study of 22 patients with CMs affecting the skin, a polarized dermoscopic photo of the lesion, and a single nucleotide variant in the EPHB4, GNA11/GNAQ, PIK3CA/PIK3R1, or RASA1 genes was performed. Three reviewers analyzed dermoscopic photos for the presence of apparent vessels, branching, lacunae, geometric shape formation, zones of dropout, follicle-sparing, vessel and background color, and length and width of vessels when discernable. Features were categorized by genotype.

resultsEPHB4-CMs have visible lengthwise and widthwise cross sections of vessels that exhibit branching. RASA1-CMs generally present with merely a red/pink/brown hue without visible vessels. GNA11 or GNAQ-CMs generally present with pink coloration and generally only with visible widthwise cross sections of vessels without branching. Geometric PIK3CA-CMs exhibit distinct purple lacunae that indicate a lymphatic component, but the reticulated PIK3CA-CMs otherwise demonstrate a varied presentation.

conclusionOur research identified distinct genotype-phenotype correlations for CMs by dermoscopy. Dermoscopy can narrow the differential diagnosis, guide genetic testing, and aid in the interpretation of variants of uncertain significance (VUS). This study demonstrates that dermoscopy holds promise in aiding genetic diagnosis and ultimately medical management.

Indexed as

CapillariesDermoscopyVascular MalformationsAdolescentChildChild, PreschoolClass I Phosphatidylinositol 3-KinasesFemaleGenotypeHumansInfantMalep120 GTPase Activating ProteinPolymorphism, Single NucleotideRetrospective StudiesClass I Phosphatidylinositol 3-Kinasesp120 GTPase Activating ProteinPIK3CA protein, humanRASA1 protein, humancapillary malformationdermoscopyEPHB4GNA11GNAQPIK3CAPIK3R1RASA1

Identifiers

PMID41063333
PMCPMC12828651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.